For many, diet and exercise alone are insufficient to reach these metrics
Secher A, Jelsing J, Baquero AF, Hecksher-Srensen J, Cowley MA, Dalbge LS, et al
How does semaglutide work
SURPASS-PEDS (NCT05260021) was a 30-week double-blind, placebo-controlled trial with a 22-week open-label extension that randomized 99 pediatric patients 10 years of age and older with type 2 diabetes mellitus with inadequate glycemic control on metformin (69%), or basal insulin (8%), or both (23%) to receive subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, or placebo once weekly as add-on therapy
Focus on lower-glycemic options like berries, apples, pears, and citrus fruits
Leave Comment Recommended for you Diabetes Management Boosting Immunity with Food: A Guide for Diabetics Boosting your immunity as a diabetic